In the News

Manufacturing’s cutting edge — custom organisms

  • March 23, 2015

Local synbio companies like Ginkgo and Cambridge-based Gen9 , which supplies much of the DNA that Ginkgo uses, are still small. But the industry “is going to grow quickly, especially in Boston,” Harvard Medical School professor Pamela Silver says. A nonprofit in Cambridge called iGEM runs an international competition that teaches college and high school students about synbio, “training the workforce of the future,” vice president Meagan Lizarazo said.

READ MORE

Joi Ito: Want to innovate? Become a “now-ist”

  • November 4, 2014

In this lab, we will have the world's capacity of gene printing within a year, 200 million base pairs a year. This is kind of like when we went from transistor radios wrapped by hand to the Pentium. This is going to become the Pentium of bioengineering, pushing bioengineering into the hands of dorm rooms and startup companies.

READ MORE

5 technologies that are shaping the future of design

  • March 11, 2014

Design isn’t just a tool for the material and digital worlds, it can also be important for the biological world....two startups working on biology-based printing including Gen9, and Organovo.

READ MORE

How Designer Microbes and the Organism Industry Will Reshape Our World

  • March 2, 2014

What would a computer be without transistors? Well, not much. A similar question can be asked of next-generation industrial biotech platforms enabled by synthetic biology...

READ MORE

Accelerating Gene Synthesis Gen9 Automates DNA Construct Production via the Use of Next-Generation Techniques

  • February 2, 2014

Gen9 believes it has found its niche in the synthetic nucleotide market by focusing on the automated production of DNA constructs. “We’re democratizing synthetic biology, making it more accessible,” says Kevin Munnelly, president and CEO. “Our scalable technology allows us to make genes, pathways, and genomes at a much larger scale.”

READ MORE

The Next Profit Breakthrough: Synthetic Biology

  • December 13, 2013

Drug, chemical, and biofuel firms are relying more than ever on artificial fragments of DNA to invent new products. It's called synthetic biology.

READ MORE

Make Mine a Double Helix (ACS members only)

  • June 23, 2013

Companies that manufacture custom-designed genes are helping pioneer the synthetic biology industry.

READ MORE

Could a Stockroom be the Next Great Scientific Revolution?

  • June 12, 2013

Are gene sequences the Legos of the future?

READ MORE

Cambridge DNA whisperers

  • April 25, 2013

Synthetic biology co. Gen9 in $21M deal

READ MORE

Gen9, a Cambridge gene synthesis firm, gets $21m investment from Agilent Technologies

  • April 24, 2013

Agilent Technologies Inc. has made a $21 million investment in Gen9 Inc., a Cambridge company specializing in gene synthesis. 

READ MORE